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We have earlier reported two 26-residue antibacterial peptides made up from different segments ofceeropin A (CA) and melittin (M). We now 
report a substantial reduction in size at the C-terminal section of the highly active hybrid CA(1-8)M(I-18), leading to a series of 20., 18- and 
15-residue analogs with antibiotic properties similar to the larger molecule. In particular, the 15-residue h2cbrids CA(I-7)M(2-9), CA(I-7)M(4-11) 
and CA(I-7)M(5-12) are the shortest ceeropin-based peptide antibiotics described so far, with antibacterial ctivity and spectra similar or better 
than cceropin A and a 60% reduction in ~ize, Their reduced size and hii3hly a-helical structure require an alternative mechanism for their interaction 
with bacterial membranes. 
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1. INTRODUCTION 
Antibacterial peptides have been known for over a 
decade now to play an important role in insect im- 
munity [1,2]. In recent years, a more general view of 
their contribution to host defense mechanisms is 
gradually emerging, as new antimicrobial peptides are 
found in amphibians, higher mammals and humans [2- 
7]. In spite of their broad antibiotic spectrum and signif- 
icant potency, attempts to develop some of these anti- 
bacterial peptides into useful, chemically synthesizable 
therapeutic agents have been sonaewhat impaired by the 
length and/or complexity of their structures. Thus ce- 
cropin A (CA), the first insect antibacterial peptide to 
be reported [8] and a rather potent antibiotic, has a 
linear but relatively long (37-residue) sequence which, 
though clearly accessible through chemical synthesis [9], 
is not an ideal candidate for drug development. PGL ", 
PYL" [10,11] and other antibiotical peptides from am- 
phibian skin such as the magalnins [3] are smaller in size 
and thus less demanding synthetically [12], but some- 
what less effective as antibiotics than the cecropins. De- 
fensins [6], on the other hand, while showing interesting 
antibacterial, antifungal and antiviral properties, are 
rather complex, highly folded structures with three in- 
ternal disulfide bonds and have so far proved rather 
difficult to prepare by chemical means [13]. 
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We have recently reported that certain hybrids of 
cecropin A and melittin (M) show powerful antibac- 
terial activities. In particular, CA(I-13)M(1-13) and 
CA(l-8) M(1-18) [14,15] exhibit a wider spectrum and 
improved potency relative to cecropln A without the 
undesirable cytotoxic effects ofmelittin. Although, at 26 
residues each, they represent a significant (30%) reduc- 
tion in size from the parent ceeropin A molecule, they 
are still relatively long and thus not yet quite appropri- 
ate for therapeutical consideration. We have therefore 
set as one of our goals to develop analogs of substan- 
tially reduced length that retain the antibacterial ctiv- 
ity of the larger molecules. In this paper we report our 
results on several shortened cecropin-melittin hybrid 
peptides, leading to a group of 15-residue analogs with 
antibacterial spectra and potency essentially com- 
parable to the larger-size peptides and which thus con- 
stitute a promising starting point for future develop- 
ment. Our findings also bear upon the current under- 
standing of the structural features involved in the anti- 
bacterial action of this family of peptides. 
2. MATERIALS AND METHODS 
2.1. Pepttde s),nthesis 
All peptides were synthesized by the solid-phase method [16] as 
C-terminal carboxamldes on p.methylbenzhydrylamine resin(0.81 
mmol/g; Peptides International, Louisville, KY) using Bee-type chem. 
i~try and 2-chlorob~nzyloxyearbonyl a d formyl side protection for 
Lys and Trp, respectively. Chain assembly was done automatically on
a 0.l-rowel scale in an Applied Biosystems 430A instrument running 
the opt21 run files provided by the manufacturer. The protected final 
peptide resins were sequentially treated with 40% (v/v) trifluoroaeetie 
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acid in dichloromethane (l + 20 rain, RT) and 20% (v/v) piperidin¢ 
in N,N-dimethylformamide (2 x 1 min, RT) to respectively the N~-Boe 
and formyl protections, then cleaved in HF-p-cresol (9:1 v/v; 0°C. I 
h). Following HF evaporation and diethyl ether extraction, the crude 
pcptides were solubillzed in 10% acetic acid, tested for purity o,1 
HPLC and lyophilized. They were purified in a single step by semi- 
preparative r verse-phase liquid chromatography on Czn-siliea using 
linear 0--40% aeetonitrile gradients in water, both containing 0.05% 
trifluoroacetic a id. Fractions judged to be of sufficient (>95%) purity 
by analytical HPLC were pooled and lyophilized. Peptide charac- 
terization was completed by amiuo acid analysis and plasma-desorp- 
tion mass spectrometry, 
2.2. Circuhtr dichroism 
Spectra were recorded on Aviv 62DS and Jasco 700 spectropolari- 
meters. Peptides were dissolved to 25 gM concentration i  2.5 mM 
sodium phosphate butter, pH %4, containing 0-20% (v/v) hexafluoro- 
2.propanol (HFIP). Three consecutive 250-190 nm scans were made 
in a l-ram cell at 10°C, averaged and fitted according to Chen and 
Yang [17] to a given ,~-hdix, g.sheet,/~-t urn and random coi! composi- 
tion by means of the Prosec program. 
2.3. Antibacterial, hemolysL~ and antimalarial ssays 
All three assays were l~rlbrmed as previously described [14]. Anti- 
bacterial and red blood cell lysis determinations were duplicated in 
independent sets of experiments (Stockholm, New York) using the 
same strains of bacteria. Lethal concentrations were calculated from 
inhibition zone diameters as described by Hultmark ctal. [18]. 
3. RESULTS 
The primary structures of the cecropin A-melittin 
hybrids reported here (one 20-mer, one 18-met and six 
15-mers) are depicted in Table I, which also includes 
CA( I-8)-M(1-18) [CA(1-8)M(I-I 8)] for comparison 
purposes. The melittin moiety of this parent structure 
was first decreased in length at its C-terminus to 12 and 
10 residues (CA(I-8)M(I-12) and CA(1-8)M(I-10), re- 
spectively), then further reduced to 8 residues with 
simultaneous removal of the lie s residue of cecropin A 
to give the pentadecapeptide CA(I-7)M(I-8). Five 
other 15-mers were prepared in which the seven N- 
terminal residues of cecropin A are followed by 8- 
residue segments of melittin beginning at the N- 
terminus and shifting in one-residue steps towards the 
Table 1 
Primary structures of parent cecropin A(l-8)-melittln(l-18) and 
shortened analogs 
Peptide name No. of Amino acid sequence 
residues 
~--cec A.--> e-- ....... melittin . . . . . .  
1 8 1 18 
CA(I-S)M(I-18) 26 KWKLFKKI G IGAVLKVLTTGLPALIS 
CA(I-8)M(I-12) 20 KWKLFKKI GIGAVLKVLTTG 
CA(I-S)M(I-10) 18 KWKLFKKI GIGAVLKVLT 
CA(I-7)M(I-8) 15 KWKLFKK GIGAVLKV 
CA(1-7)M(2-9) 15 KWKLFKK IGAVLKVL 
CA(I-7)M(3-10) 15 KWKLFKK GAVLKVLT 
CA(I-7)M(4-1 I) 15 KWKLFKK AVLKVLTT 
CA(I-7)M(5-12) 15 KWKLFKK VLKVLTTG 
CA(I-7)M(6-13) 15 KWKLFKK LKVLTTGL 
C-terminus. All peptides were prepared as C-terminal 
amides by automated solid phase synthesis using op- 
timized Boc/ben~l chemistry, cleaved in HF and 
purified by reverse-phase chromatography in satis- 
factory yields (40-45%, combined cleavage and pu- 
rification). They were found to be pure and of the 
correct structure on the basis of their amino acid ana- 
lyses, HPLC homogeneity and mass spectra. 
The solution conformations of the peptides were 
measured by circular dichroism at different concentra- 
tions of HFIP (0% to 20%, v/v, in 4% intervals), Two 
different types of conformational behavior could be 
broadly defined from these experiments (Tabel I1). On 
the one hand, peptides CA(I-8)M(I-I 2), CA(I-8)M( 1- 
10) and CA(I-7)M(I-8) in the absence of HFIP (5 mM 
sodium phosphate, pH 7.3) gave curves suggestive of 
significant levels of ,0-sheet structure which remained 
the prevalent conformation feature also in the 4--12% 
HFIP interval. Some incipient so-helix formation was 
observed even at 4% HFIP and, as expected, it rose to 
a plateau of ca. 50% helix at 16-20% HFIP, the highest 
concentrations of organic solvent studied. The other 
15-residue peptides behaved somewhat differently. In 
the absence of organic solvent no defined structure was 
observed and, while moderate-to-medium levels of/~ 
structure were calculated for all five peptides at low 
(4-8%) HFIP concentrations, a much stronger tendency 
to adopt an g-helix structure became vident at 12% 
HFIP and higher, with no p-sheet present. Indeed, 
CA(1-7)M(2-9) was calculated by the Preset program 
to be a "perfect' ~-helix at 16% HFIP and above (Fig. 
1). The high helix contents of the peptides at and above 
12% HFIP were found to be indepe,adent of the con- 
centration in the 5-50/,tM range (data not shown): at 
higher concentrations some loss of helieity was ob- 
served indicating possible aggregation. It should be no- 
ticed that the consistently high levels of ~-helix found 
for all 15-residue hybrids except CA(I-7)M(I-8) (Table 
II) seem to.be compatible with the presence of a single 
Gly residue in their central section, while in CA(I-. 
7)M(1-8) and the larger hybrids the presence of the 
Oly-Ile-Gly-Ala tetrapeptide would appear to disrupt 
the helix continuity. 
The antibiotic and hemolytic activity of the peptides 
were measured by inhibition zone assays from which 
lethal concentrations were derived (Table lIl). Dupli- 
cate assays were performed independently in two of our 
laboratories and good correlation between them was 
found. Deviations in lethal concentration values from 
one assay to another were always within the __.50% ex- 
perimental error range. All peptides were shown to be 
active against both Gram-negative and Gram-positive 
test microorganisms, in most cases at peptide con- 
centrations similar to those of the parent analog CA(I-  
S)M(1-18). Thns, CA(1-8)M(I-12) and CA(I-8)M(I-  
10) were essentially comparable to CA(1-8)M(I-18), 
although the latter analog showed a significant reduc- 
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Table Il 
Calculated percentages" of a.helix, 8.sheet and random coil in cecropin A-melittin hybrids 
January 1992 
Pcpt[de 0% HFIP 4% HFIP 8% HFIP 12% HFIP 16% HFIP 20% HFIP 
CA(I-8)M(I-12) 0 35 58 9 52 37 17 52 31 35 37 28 52 18 30 56 6 38 
CA(I-8)M(1-10) 0 33 62 6 41 43 5 56 33 23 46 31 48 21 31 52 12 36 
CA( I-7)M(1-8) 0 21 60 0 16 50 0 52 35 13 52 35 41 18 41 44 25 31 
CA(I-7)M(2-9) 0 0 69 0 8 62 28 63 9 91 0 9 100 0 0 100 0 0 
CA(I-7)M(3-10) 0 0 65 0 i I 59 0 44 45 63 0 37 91 0 9 100 0 0 
CA(1-7)M(4-11) 0 0 69 0 19 67 0 33 53 75 0 25 88 0 12 90 0 10 
CA(I-7)M(5-12) 0 0 69 0 22 56 35 33 32 78 0 22 82 0 18 88 0 12 
CA(I-7)M(6-13) 0 4 62 0 13 57 0 53 36 75 0 25 88 0 12 90 0 10 
"In cases where the sum of percentages is less than 100%, the remainder ispredicted as a turn. 
t ion in activity against S. aureus .  Of the six pentadeca- 
peptides, CA(1-7)M( I -8)  tested poorly against most  or- 
ganisms, but the other five showed antibacterial ctivity 
values within the same range as the parent structures. 
CA(1-7)M(2-9),  CA(1-7)M(4-- l l )  and CA( I -7 )M(5-  
12), in particular, were essentially indistinguishable 
f rom the larger molecules in terms of molar  antibiotic 
potency. In addition, all 15-residue peptides were also 
tested for antimalarial activy agains P. fa l c iparurn .  In a 
reinvasion inhibition assay (Table IV), their activity was 
shown to be in most  cases only slightly inferior to their 
parent structure, CA(I -8)M(1-18),  and significantly 
better than a number of larger antibacterial pcptides. 
cropin A-melitt in hybrids with improved antibacterial 
spectra and potencies relative to cecropin A [14,15]. 
CA( I -8)M(1-18) [CA(I-8)M(1-18)],  oae of  the most 
active hybrids of  this series, was chosen as a starting 
point for our present search. Since it is well known that 
the N-terminal section of  cecropin A, while not suffi- 
cient in itself as an antibacterial agent, is nevertheless 
needed for optimal activity [8], we chose to explore the 
e.flect of deletions at the C-terminal melittin port ion of  
CA( I -8)M(1-18) .  An encouraging initial finding was 
that removal o f  six or eight residues from the C- 
terminus of  CA(1-8)M( I -18)  did not significantly alter 
the biological activity of  the resulting peptides. Thus, 
4. D ISCUSSION 
The aim of  this study was to develop ceeropin A -  
melittin hybrids of relatively simple structure that 
would be easily accessible by chemical synthesis and 
thus have increased therapeutic potential. For  cecropin 
A it has been known for some time that the broad 
spectrum antibiotic activity decreased when the mole- 
cule was shortened by deletion of  certain residues [8,19]. 
However,  we recently reported several 26-residue ce- 
10[-, , L . . . .  
F i ~ Catl-71Mtl.e} -o -  
' ~ ~N~ eA (1"/)H12"9] --0-- 
' /" ~.~\ r £t l '7}M[~'10)  - -a - -  
~ "~\ ~Al~-7~.t~.11~-,- 
'0 
26o 2io 2zo 2go 2io ago 
Wavo longth  (nm)  
Fig. 1. Circular dichroism Slx~tra of 15 r~idac ¢,~ropin A-m¢littin 
hybrids (25/~M) at 10'C in 2.5 mM sodium phospate, pH 7.4, con- 
taining 20% (v/v) hexaflaoroL~opropanol. 
Table III 
Antibiotic and lytic activity ofcecropln A-melittin hybrids and parent 
compounds 
Peptide Lethal concentration" ~M) 
D21 OT97 Bsll Bmll $taph. Strep. SRC 
cecropin A b 0.3 2 4 0.5 >200 4 >400 
melittin ~ 0.8 3 0.2 0.6 0.2 0.5 4-8 
CA(1-13)M(I-I 3) ~ 0.5 1 0.7 2 1 >500 
CA(I-8)M(I-18) c 0.3 0.7 0.4 0.4 1 2 >600 
CA(I-8)M(I-12) 0.4 0.9 0,3 0.2 2 0.1 >600 
CA(I-8)M(I-10) 0.5 3 0.3 0.5 7 0.8 >600 
CA(I-7)M(I-8) 4 15 1.4 0.8 29 0.7 >300 
CA(I-7)M(2-9) 1 4 0,5 0.7 2 0.5 >300 
CA(I-7)M(3-10) 3 15 3 0.9 >200 1 >600 
CA(I-7)M(4-11) 0.6 4 0,6 0.5 8 0.7 >600 
CA(I-7)M(5-12) 0.5 2 0.3 0.5 8 0.4 >500 
CA(I-7)M(6-13) 2 8 1 0.5 51 0.4 >500 
"Calculated from inhibition zones on thin agarose plates eeded with 
the r~pcetiv¢ organisms. Test strains arc: D21 = E. call D21; OT97 = 
P. aerugLnosa O"!"9.7; Bs!i = B. subti!is; Bm!l -- B. megaterium: 
Staph. = S. aureus Cowan 1; Strep. = S. pyogenes: SRC = sheep red 
cells, 
b Data from [81. 
"Data from [13]. 
192 
Volume 296. number 2 FEBS LETTERS January 1992 
Table IV 
Antimalarial (P./alc'iparum) activity of natural antibacterial peptides 
and ceeropin A-melittin hybrids 
Peptide 50% reinvasion 
inhibition (.uM) 
Cceropin A n,a." 
Cecropin B 110 
Cecropin P-I 90 
Magainin 80 
PG L" 40 
CA(I-13)M(I-13) 17 
CA(I-8)M(I-18) 4 
CA(I-7)M(I-8) 7.0 
CA(I-7)M(2-9) 7.5 
CA(I-7)M(3-10) 8.0 
CA( 1-7)M(4-11 ) 8.0 
CA(1-7)N1(5-12) 9.0 
CA(I-7)M(6-13) 9.0 
*n.a. = no activity. 
Table III shows that activity against S pyogenes in- 
creased by a factor of 20 when the hybrid was shortened 
from 26 to 20 residues. A farther decrease insize [CA(I- 
8)M(I-10) did have only a small but probably signifi- 
cant effect. In addition, both peptides were found to be 
non-cytotoxic (i.e. non-hemolytic), a desirable property 
in any antibacterial gent. These results stimulated a
search for structures of even smaller size and com- 
parable activity that resulted in six 15-residue hybrids 
(Table 1) in which seven N-terminal residues ofcecropin 
A are followed by a segment of eight consecutive 
residues from melittin. While the first member of this 
series, CA(I-7)M(1-8), was not a very effective antibac- 
terial agent, the other five retained significant potency, 
in some eases [CA(1-7)M(2-9) and CA( I-7)M(5-12)] 
comparable to the larger structures. The latter peptides 
are the shortest (60% reduction in size relative to ce- 
cropin A), most active cecropin-based antibiotics de- 
scribed to date and show interesting antimalarial 
properties as well. Work at our laboratories i  currently 
aimed at a wider exploration of their antimicrobial 
spectrum and therapeutical possibilities. We believe 
their structures hould provide helpful leads in the 
search for even smaller antibacterial peptide molecules. 
The present finding that pentadecapeptides rived 
fi'om cecropin A are powerful antibiotics must be re- 
conciled with our previous ion-channel model for the 
membrane activity of the cecropins [15]. Up until now 
we had examined cecropin-based peptides of such a 
length (26-37 residues) that could be assumed to span 
the ca. 30 A-thick membrane of a bacterial cell. Most 
of these peptides could be viewed as two 0t-helical seg- 
ments eparated by a Gly-Pro-eontaining 'hinge' region 
providing the necessary conformational flexibility re- 
quired for membrane channel formation [15,19,20]. In 
the previously described CA(1-13)M(I-13) and CA(I-  
S)M(1-18) hybrids, the melittin-derived Gly-Ile-Giy- 
Ala tetrapeptide located at the middle of the sequence 
might play a similar role. In agreement with this model, 
the antibacterial activity of the larger (20- and 18- 
residue) peptides in the present series could still be ex- 
plained by making allowance for some flexibility in the 
membrane-spanning ability of the peptides. Our present 
findings, however, showing several 15-residue peptides 
to be powerful membrane-active antibiotics while 
achieving remarkably high levels of g-helix (and thus 
total spans of ca. 22.5 A, clearly shorter than the bac- 
terial membrane thickness), seem to point towards a 
slightly different mechanism for antibacterial ction. 
The possibility that the peptides adopt a 31o helix con- 
formation (total length 30/k) instead of an g-helix is an 
attractive model that needs to be investigated. Another 
alternative is that the peptides associate in non-covalent 
form to give dimerie or multimeric structures spanning 
the entire membrane. Until further experimental testing, 
however, caution should be exercised in the interpreta- 
tion of these results. Recent solid phase NMR work [21] 
has shown magainin, a membrane channel-forming 
peptide [22], to interact with membranes in a parallel 
fashion while another membrane-active peptide did in- 
teract perpendicular to the membrane. It may therefore 
be too early to suggest a general mechanism of action 
for the present short cecropin A-melittin hybrids, if 
indeed a single mechanism is involved. 
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